Novartis AG raised $11 billion to help fund its purchase of Avidity Biosciences Inc., adding to a flurry of buyout-related bond sales.
Avidity Biosciences offices in San Diego, California, US, on Monday, Oct. 27, 2025. Novartis AG is nearing a deal to buy biotechnology company Avidity Biosciences Inc., according to a person familiar with the matter.
Anmelden
